Pathology and Clinical Laboratory Division, National Cancer Center Hospital, Tokyo, Japan.
Am J Surg Pathol. 2011 Aug;35(8):1226-34. doi: 10.1097/PAS.0b013e3182233e06.
A subset (1% to 5%) of non-small-cell lung carcinomas harbors the EML4-ALK fusion gene. Data from previous studies on the histomorphology of ALK-rearranged lung cancer are inconsistent, and the specific histologic parameters that characterize this subset and how accurately such parameters predict underlying ALK abnormality remain uncertain. To answer these questions, we performed a comprehensive histologic analysis of 54 surgically resected, extensively sampled ALK-rearranged lung carcinomas and compared them with 100 consecutive resections of ALK-wild-type lung cancers. All 54 cases showed at least a focal adenocarcinoma component, and 3 and 2 cases had additional squamous and sarcomatoid differentiation, respectively. Solid or acinar growth pattern, cribriform structure, presence of mucous cells (signet-ring cells or goblet cells), abundant extracellular mucus, lack of lepidic growth, and lack of significant nuclear pleomorphism were more common in ALK-positive cancers. Two recognizable constellations of findings, a solid signet-ring cell pattern and a mucinous cribriform pattern, were present at least focally in the majority (78%) of ALK-positive tumors, but were rare (1%) in ALK-negative tumors. Multivariate analysis showed that a combination of these 2 patterns was the most powerful histologic indicator of ALK rearrangement. Characteristic histologies were present both in primary sites and in metastases. Thus, histologic findings may help to identify cases for ALK testing. However, none of the histologic parameters were completely sensitive or specific to ALK rearrangement, and histomorphology should not replace confirmatory molecular or immunohistochemical studies. ALK-positive cancers commonly showed coexpression of thyroid transcription factor-1 and p63, and its significance is currently unclear.
一小部分(1%至 5%)非小细胞肺癌具有 EML4-ALK 融合基因。先前关于 ALK 重排肺癌组织形态学的数据不一致,并且特征这种亚型的具体组织学参数以及这些参数如何准确预测潜在的 ALK 异常仍不确定。为了回答这些问题,我们对 54 例经手术切除的广泛采样的 ALK 重排肺癌进行了全面的组织学分析,并将其与 100 例连续的 ALK 野生型肺癌切除术进行了比较。所有 54 例均至少显示局灶性腺癌成分,分别有 3 例和 2 例具有额外的鳞状和肉瘤样分化。实性或腺泡生长模式、筛状结构、黏液细胞(印戒细胞或杯状细胞)存在、丰富的细胞外黏液、缺乏贴壁生长和缺乏明显的核多形性在 ALK 阳性癌症中更为常见。两种可识别的发现组合,实性印戒细胞模式和黏液性筛状模式,至少在大多数(78%)ALK 阳性肿瘤中局灶性存在,但在 ALK 阴性肿瘤中很少见(1%)。多变量分析表明,这两种模式的组合是 ALK 重排的最有力的组织学指标。特征性组织学在原发灶和转移灶中均存在。因此,组织学发现可能有助于识别需要进行 ALK 检测的病例。然而,没有任何组织学参数对 ALK 重排完全敏感或特异,组织形态学不应替代确认性分子或免疫组织化学研究。ALK 阳性癌症通常表现为甲状腺转录因子-1 和 p63 的共表达,其意义目前尚不清楚。